Tandem: Upgrading To Hold On A High-Stakes Pivot Story
Source: SeekingAlpha
2026-06-04 09:37:32 ET
Things weren't looking too hot when I last assessed Tandem Diabetes Care, Inc. ( TNDM ). Despite a small headline Q2 2025 revenue beat, the company missed big on EPS and made a downward revision to its full-year 2025 U.S. sales guidance. I also touched on the competitive landscape within the insulin pump market that featured larger and more established players like Insulet ( PODD ) and Medtronic ( MDT )....
Read the full article on Seeking Alpha
For further details see:
Tandem: Upgrading To Hold On A High-Stakes Pivot Story
Tandem Diabetes Care Inc.
NASDAQ: TNDM
TNDM Trading
4.35% G/L:
$19.81 Last:
221,938 Volume:
$19.53 Open:
TNDM Latest News
TNDM Stock Data
$1,337,401,531
66,514,114
0.48%
99
N/A
Medical Equipment & Supplies
Healthcare
US
San Diego
